Dianthus Therapeutics (DNTH) Enterprise Value Growth (5y) (2022 - 2025)

Dianthus Therapeutics (DNTH) Enterprise Value Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Dianthus Therapeutics 4.97 Bn 4.57 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -22.12%
Sep 30, 2025 -20.01%
Jun 30, 2025 -7.84%
Mar 31, 2025 -15.08%
Dec 31, 2024 -13.56%
Sep 30, 2024 -11.85%
Jun 30, 2024 -15.93%
Mar 31, 2024 -24.25%
Dec 31, 2023 -4.03%
Sep 30, 2023 -3.50%
Jun 30, 2023 20.47%
Dec 31, 2022 -7.92%
Sep 30, 2022 -12.10%
Jun 30, 2022 -16.93%